Subscribe To
Taysha gene therapies: tsha-102's potential is a 'buy'
Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...
November 3, 2023, 7:41 pm
Lirum therapeutics presents positive data on lx-101, a novel clinical-stage targeted therapy, demonstrating potent preclinical activity against pediatric sarcomas
New York, NY, Oct. 31, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focuse...
October 31, 2023, 5:27 pm
Hematology analyzers market poised to reach $2.20 billion by 2033 amid rising pediatric blood disorder cases and continuous innovation: report by persistence market research
Rising blood disorder prevalence propels the U.S. to capture 90.3% market share in North America’s hematology analyzer market in 2022 New York, Oct....
October 25, 2023, 11:16 am
Accarent health offers industry leading pediatric network of excellence
Robust portfolio of services offers improved outcomes and reduced costs for both patients and employers Baltimore, MD, Oct. 23, 2023 (GLOBE NEWSWIRE) ...
October 23, 2023, 4:48 pm
Orthopediatrics corp. launches pediatric nailing platform | tibia
WARSAW, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“Ortho...
October 19, 2023, 12:05 pm
Pfizer will charge up to $1,400 for covid drug paxlovid
The pill is designed to treat Covid-19 in adults and pediatric patients with a high risk for developing...
October 18, 2023, 8:48 pm
Orthopediatrics corp. to report third quarter 2023 financial results on november 7, 2023
WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“Ortho...
October 17, 2023, 8:05 pm
Orthopediatrics corp. to report third quarter 2023 financial results on november 7, 2023
WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Orthopediatrics Corp. (“Ortho...
October 17, 2023, 4:05 pm
Strength seen in orthopediatrics (kids): can its 8.1% jump turn into more strength?
Orthopediatrics (KIDS) was a big mover last session on higher-than-average trading volume. The latest t...
October 17, 2023, 9:46 am
Orthopediatrics joins alliance for pediatric device innovation
WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“Ortho...
October 12, 2023, 12:05 pm
Arpa-h awards $3.5 million contract to belletorus corp. (belle.ai) to expand pediatric healthcare access using artificial intelligence
Initiative aims to enable at-home and at-school remote pediatric evaluation using smartphone images of ...
October 11, 2023, 10:12 am
Neurocrine's crinecerfont delivered, but the street has been slow to reward the success
Neurocrine Biosciences has reported very positive Phase III results for crinecerfont in adult and pediatric...
October 11, 2023, 3:44 am
Orthopediatrics corp. launches df2 brace®
WARSAW, Ind., Oct. 10, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“Ortho...
October 10, 2023, 12:05 pm
Fda accepts sanofi's (sny) sbla for dupixent in pediatric eoe
If this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved treatment for eosinophilic esophagitis in children...
September 26, 2023, 9:46 am
Orthopediatrics was a gold level sponsor of the scoliosis research society 58th annual meeting
WARSAW, Ind., Sept. 25, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“Ortho...
September 25, 2023, 12:05 pm
Ascendis pharma presents results from long-term enlighten trial of transcon™ hgh in pediatric growth hormone deficiency
– The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) met or exceeded average parental height SDS at ...
September 23, 2023, 11:00 am
Orchard's (ortx) rare neuro drug gets fda priority tag, stock up
Orchard's (ORTX) regulatory filing for OTL-200, in the treatment of pediatric patients suffering from m...
September 19, 2023, 11:18 am
Otc pediatric healthcare market to reach us$ 18 billion at a cagr of 5% by 2033, states fact.mr
Increasing preference for self-medication and non-prescription remedies among parents and caregivers is fueling the growth of the OTC ...
September 13, 2023, 7:00 am
Aquestive's (aqst) libervant accepted for fda review, stock up
Aquestive (AQST) announces FDA acceptance of a regulatory application seeking approval for Libervant to treat ...
September 12, 2023, 9:50 am
Lumos pharma announces participation in investor conferences in september
AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidat...
September 7, 2023, 4:34 pm